UTSW Clinical Research Unit (CRU)/Investigational Drug Service (IDS)

Overview of Services

The Clinical Research Unit (CRU) and the Investigational Drug Service (IDS) at UT Southwestern’s Center for Translational Medicine (CTM) are institutional resource for translational investigators designed to support the safe and ethical conduct of research while enhancing the research experience for study participants. The CRU and IDS provide a set of standard, cost-effective services to supplement resources provided through investigators' own departments and clinics.


The CRU/IDS staff are dedicated to providing excellent customer service and employing best practices for research procedures to ensure each protocol is managed efficiently and accurately.  Overall, the CRU/IDS strives to be the gold standard of research on campus, providing high-quality, cost-effective research resources and services that facilitate superior translational research outcomes. 



Services offered by the CTM CRU and IDS include:

  • Two outpatient clinics (Aston and Sprague)
  • Research Nursing Services
  • Facility-usage-only Visit
  • Drug Infusions, Phlebotomy, EKGs, etc.
  • Nutrition services, including meal design, preparation, nutrition assessment, education, and counseling, and food record nutrient analysis.
  • Basic laboratory services or usage of laboratory facilities and equipment
  • Clinical Research Coordinator services
  • Research pharmacy services, including drug randomization, dispensation, and storage
  • Inpatient services at Zale-Lipshy Hospital



  • Robert D. Toto, MD - Medical Director
  • Jaime Almandoz, MD - Assistant Medical Director
  • Maureen Osanjo, BSN, RN - Nurse Supervisor
  • Michael Phan, Pharm D, MBA - Sr. Pharmacist
  • Lisa Fleming, MPA - CRU Business Manager

Location and hours of operation


Hours of Operation

Sprague Outpatient Clinic

7:30AM – 5:00PM


Aston Outpatient Clinic (Clinical Trials Office)

7AM – 4PM


Zale-Lipshy Inpatient Services


Must be requested and scheduled through the CRU at least 5 business days in advance

Investigational Drug Service

8AM - 5PM


Citation of Grant Support

The National Institutes of Health (NIH) requires that investigators who use Center for Translational Medicine (CTM) services such as the Clinical Research Unit (CRU), the Investigational Drug Service (IDS), or the related facilities or equipment acknowledge that support in all publications, presentations, and posters by stating the following: “Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL1TR001105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”


Additionally, in accordance with the NIH Public Access Policy, investigators must submit, via the NIH Manuscript Submission System, to PubMed Central an electronic version of their final, peer-reviewed manuscript immediately upon acceptance for publication.

Links and Resources

  1. http://www.utsouthwestern.edu/research/translational-medicine/doing-research/ctrc/index.html


Name Role Phone Email Location
Lisa Fleming, MPA
CRU Business Manager

Michael Phan, PharmD, MBA
Sr. Pharmacist

Lona Sandon, PhD, RD, LD